{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T15:18:12Z","timestamp":1785683892008,"version":"3.56.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":1340,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1038\/jid.2011.464","type":"journal-article","created":{"date-parts":[[2012,2,2]],"date-time":"2012-02-02T13:29:17Z","timestamp":1328189357000},"page":"1247-1252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Prognostic Importance of the Mitotic Marker Phosphohistone H3 in Cutaneous Nodular Melanoma"],"prefix":"10.1016","volume":"132","author":[{"given":"Rita G.","family":"Ladstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingeborg M.","family":"Bachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oddbj\u00f8rn","family":"Straume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars A.","family":"Akslen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2011.464_bb0010","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1111\/j.1755-3768.2009.01769.x","article-title":"Immunohistochemical assessment of mitotic count in uveal melanoma","volume":"89","author":"Angi","year":"2011","journal-title":"Acta Ophthalmol"},{"key":"10.1038\/jid.2011.464_bb0015","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1309\/LB7RTC61B7LC6HJ6","article-title":"Mitotic rate in melanoma: a reexamination","volume":"127","author":"Attis","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/jid.2011.464_bb0020","first-page":"325","article-title":"Melanoma of the skin","author":"Balch","year":"2009"},{"key":"10.1038\/jid.2011.464_bb0025","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1038\/jid.2011.464_bb0030","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/00000658-197011000-00017","article-title":"Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma","volume":"172","author":"Breslow","year":"1970","journal-title":"Ann Surg"},{"key":"10.1038\/jid.2011.464_bb0035","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/DAD.0b013e3181cf7cc1","article-title":"Useof anti-phosphohistone H3 immunohistochemistry to determine mitotic rate in thin melanoma","volume":"32","author":"Casper","year":"2010","journal-title":"Am J Dermatopathol"},{"key":"10.1038\/jid.2011.464_bb0040","first-page":"705","article-title":"The histogenesis and biologic behavior of primary human malignant melanomas of the skin","volume":"29","author":"Clark","year":"1969","journal-title":"Cancer Res"},{"key":"10.1038\/jid.2011.464_bb0045","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/DAD.0b013e3181d7ce6f","article-title":"Frequent mitotic activity in banal melanocytic nevi uncovered by immunohistochemical analysis","volume":"32","author":"Glatz","year":"2010","journal-title":"Am J Dermatopathol"},{"key":"10.1038\/jid.2011.464_bb0050","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1038\/jid.2011.464_bb0055","doi-asserted-by":"crossref","first-page":"24470","DOI":"10.1074\/jbc.273.38.24470","article-title":"Chromatin condensation is not associated with apoptosis","volume":"273","author":"Hendzel","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1038\/jid.2011.464_bb0060","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s004120050256","article-title":"Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation","volume":"106","author":"Hendzel","year":"1997","journal-title":"Chromosoma"},{"key":"10.1038\/jid.2011.464_bb0065","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/(SICI)1097-0320(19980601)32:2<71::AID-CYTO1>3.0.CO;2-H","article-title":"Histone H3 phosphorylation and expression of cyclins A and B1 measured in individual cells during their progression through G2 and mitosis","volume":"32","author":"Juan","year":"1998","journal-title":"Cytometry"},{"key":"10.1038\/jid.2011.464_bb0070","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1471-2407-10-140","article-title":"Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma","volume":"10","author":"Ladstein","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1038\/jid.2011.464_bb0075","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/DAD.0b013e3181624054","article-title":"Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions","volume":"30","author":"Nasr","year":"2008","journal-title":"Am J Dermatopathol"},{"key":"10.1038\/jid.2011.464_bb0080","first-page":"205","article-title":"Pathology of melanoma","author":"Scolyer","year":"2009"},{"key":"10.1038\/jid.2011.464_bb0085","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1097\/00000478-200312000-00011","article-title":"Interobserver reproducibility of histopathologic prognostic variables in primary cutaneous melanomas","volume":"27","author":"Scolyer","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/jid.2011.464_bb0090","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1038\/modpathol.3800972","article-title":"Phosphohistone H3 expression has much stronger prognostic value than classical prognosticators in invasive lymph node-negative breast cancer patients less than 55 years of age","volume":"20","author":"Skaland","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1038\/jid.2011.464_bb0095","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0002-9440(10)61688-4","article-title":"Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas","volume":"159","author":"Straume","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1038\/jid.2011.464_bb0100","first-page":"1845","article-title":"Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma","volume":"6","author":"Straume","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1038\/jid.2011.464_bb0105","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/01.pas.0000183572.94140.43","article-title":"Two mitosis-specific antibodies, MPM-2 and phospho-histone H3 (Ser28), allow rapid and precise determination of mitotic activity","volume":"30","author":"Tapia","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/jid.2011.464_bb0110","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1200\/JCO.2010.31.5812","article-title":"Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional american joint committee on cancer melanoma staging database","volume":"29","author":"Thompson","year":"2011","journal-title":"J Clin Oncol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15357122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15357122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T17:52:20Z","timestamp":1743961940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15357122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0022202X15357122"],"URL":"https:\/\/doi.org\/10.1038\/jid.2011.464","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Importance of the Mitotic Marker Phosphohistone H3 in Cutaneous Nodular Melanoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2011.464","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}